This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Rep. Diana DeGette
degette.house.gov
did:plc:knadvieuh3xnszynv67gwjck
(1/2) All the experts agree: FDA should simplify access to complex treatments for people with severe Type 1 Diabetes.
That's why Rep. Bilirakis and I sent a bipartisan letter to the FDA urging the agency to revisit its policies so that more patients can be helped.
2026-05-20T01:01:43.172Z